Document is current
Any future updates will be listed below
-
Authors
Siegal, E. Z.
Schoevers, J. M. H.
Terstappen, J. https://orcid.org/0000-0003-2986-0138
Delemarre, E. M.
Johnston, S. L. https://orcid.org/0000-0003-3009-9200
van Beek, L. F.
Bogaert, D. https://orcid.org/0000-0003-2651-7000
Chiu, C. https://orcid.org/0000-0003-0914-920X
Diavatopoulos, D. A. https://orcid.org/0000-0001-7065-7807
Ferreira, D. M.
Gordon, S. B.
Hayden, F. G. https://orcid.org/0000-0001-8707-0375
de Jonge, M. I. https://orcid.org/0000-0003-2812-5895
McCall, M. B. B.
McShane, H. I. https://orcid.org/0000-0002-2126-5142
Minassian, A. M.
Openshaw, P. J. M. https://orcid.org/0000-0002-7220-2555
Pollard, A. J. https://orcid.org/0000-0001-7361-719X
Sattabongkot, J. https://orcid.org/0000-0002-3938-4588
Read, R. C. https://orcid.org/0000-0002-4297-6728
Troelstra, A.
Viveen, M. C.
Wilder-Smith, A.
van Wijk, M.
Bont, L. J. https://orcid.org/0000-0003-3099-4475
Mazur, N. I.
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 26 March 2025
First Online: 15 April 2025
Competing interests
: P.J.M.O. has been a paid member of scientific advisory boards for GSK, Moderna, Janssen, Seqirus, Pfizer, Sanofi, AstraZeneca, and Icosavax and a co-investigator on EU IMI awards, RESCEU and PROMISE, investigating the impact of RSV disease in Europe. F.G.H. has participated on a Data Safety Monitoring Board or Advisory Board, has participated in DSMB committees for RSV antiviral (Enanta), COVID therapeutic (Cytodyn, Enanta), influenza vaccine (Vaccitech) and is a non-paid consultant on RSV antivirals (Pfizer, Enanta). N.I.M. and L.B. have received support for attending meetings and/or travel from the ResViNET Foundation. UMC Utrecht has received grants from AbbVie, AstraZeneca, The Bill & Melinda Gates Foundation, the Dutch Lung Foundation, The Gates Medical Research Institute, GSK, Janssen, MedImmune, MeMed, Merck, Novavax, Pfizer, and Sanofi; has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AbbVie, Ablynx, Astrazeneca, Bavaria Nordic, GSK, Janssen, MabXience, MedImmune, MEDtalks, Merck, Moderna, Novavax, Pfizer, and Sanofi and Virology Education. L.B. is founding chairman of the ReSViNET Foundation. M.B.B.M. has served as (unpaid) Local Safety Monitor on two inpatient LPS challenge studies, as well as (unpaid) on the Safety Monitoring Committee of amongst others an outpatient Loa loa treatment trial. Furthermore, he is, and has been, PI or senior co-investigator on various outpatient Controlled Human Malaria Infection studies. A.J.P. is chair of the UK Department of Health’s Joint Committee on Vaccination and Immunization, which advises the UK Government on vaccine policy including the use of immunization for prevention of RSV infection.
